SCHEMBL13618610

SCHEMBL13618610

F[C@@H]1CCC[C@@H]1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1067063 1.00
SCHEMBL21017220 0.95
SCHEMBL24425442 0.90
SCHEMBL60925 0.90
SCHEMBL7026108 0.86 ALDH1A1 (0.36)
SCHEMBL868375 0.86
SCHEMBL708464 0.82
SCHEMBL24425424 0.82
SCHEMBL24637544 0.78
SCHEMBL21017223 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024219479-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE EAファーマ株式会社 2024-10-24 WO disclosed
US-11718602-B2 EGFR inhibitors BLUEPRINT MEDICINES CORPORATION (US) 2023-08-08 US disclosed
EP-2275414-B1 CYCLOPENTYLACRYLAMIDE DERIVATIVE KYORIN SEIYAKU KK (JP) 2015-06-10 EP disclosed
EP-2116535-B1 GLUCOKINASE-ACTIVATING SUBSTANCE KYORIN SEIYAKU KK (JP) 2014-06-11 EP disclosed
EP-2116533-A1 GLUCOKINASE ACTIVATOR Kyorin Pharmaceutical Co., Ltd. (JP) 2009-11-11 EP disclosed
EP-2116535-A1 GLUCOKINASE-ACTIVATING SUBSTANCE Kyorin Pharmaceutical Co., Ltd. (JP) 2009-11-11 EP disclosed